| Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017 C Hiemke, N Bergemann, HW Clement, A Conca, J Deckert, K Domschke, ... Pharmacopsychiatry 51 (01/02), 9-62, 2018 | 1489 | 2018 |
| AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011 C Hiemke, P Baumann, N Bergemann, A Conca, O Dietmaier, K Egberts, ... Pharmacopsychiatry 21 (06), 195-235, 2011 | 1136 | 2011 |
| Kompendium der psychiatrischen Pharmakotherapie O Benkert, H Hippius, I Anghelescu, E Davids, G Gründer, ... Springer Berlin Heidelberg, 2013 | 1054 | 2013 |
| Correlation Between Dopamine D2 Receptors in the Ventral Striatum and Central Processing of Alcohol Cues and Craving A Heinz, T Siessmeier, J Wrase, D Hermann, S Klein, ... American Journal of Psychiatry 161 (10), 1783-1789, 2004 | 738 | 2004 |
| Drug interactions at GABAA receptors ER Korpi, G Gründer, H Lüddens Progress in neurobiology 67 (2), 113-159, 2002 | 654 | 2002 |
| Anticipation of monetary and social reward differently activates mesolimbic brain structures in men and women KN Spreckelmeyer, S Krach, G Kohls, L Rademacher, A Irmak, K Konrad, ... Social cognitive and affective neuroscience 4 (2), 158-165, 2009 | 504 | 2009 |
| Dissociation of neural networks for anticipation and consumption of monetary and social rewards L Rademacher, S Krach, G Kohls, A Irmak, G Gründer, KN Spreckelmeyer Neuroimage 49 (4), 3276-3285, 2010 | 418 | 2010 |
| Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C] raclopride F Yokoi, G Gründer, K Biziere, M Stephane, AS Dogan, RF Dannals, ... Neuropsychopharmacology 27 (2), 248-259, 2002 | 415 | 2002 |
| Correlation of Alcohol Craving With Striatal Dopamine Synthesis Capacity and D2/3 Receptor Availability: A Combined [18F]DOPA and [18F]DMFP PET Study in … A Heinz, T Siessmeier, J Wrase, HG Buchholz, G Gründer, Y Kumakura, ... American Journal of Psychiatry 162 (8), 1515-1520, 2005 | 330 | 2005 |
| Mechanism of new antipsychotic medications: occupancy is not just antagonism G Gründer, A Carlsson, DF Wong Archives of general psychiatry 60 (10), 974-977, 2003 | 273 | 2003 |
| Oxytocin influences processing of socially relevant cues in the ventral tegmental area of the human brain SE Groppe, A Gossen, L Rademacher, A Hahn, L Westphal, G Gründer, ... Biological psychiatry 74 (3), 172-179, 2013 | 254 | 2013 |
| Association of Low Striatal Dopamine D 2 Receptor Availability With Nicotine Dependence Similar to That Seen With Other Drugs of Abuse C Fehr, I Yakushev, N Hohmann, HG Buchholz, C Landvogt, H Deckers, ... American Journal of Psychiatry 165 (4), 507-514, 2008 | 249 | 2008 |
| Oxytocin plasma concentrations after single intranasal oxytocin administration–a study in healthy men A Gossen, A Hahn, L Westphal, S Prinz, RT Schultz, G Gründer, ... Neuropeptides 46 (5), 211-215, 2012 | 247 | 2012 |
| Dopamine in amygdala gates limbic processing of aversive stimuli in humans T Kienast, AR Hariri, F Schlagenhauf, J Wrase, P Sterzer, HG Buchholz, ... Nature neuroscience 11 (12), 1381-1382, 2008 | 233 | 2008 |
| The thalamus as the generator and modulator of EEG alpha rhythm: a combined PET/EEG study with lorazepam challenge in humans M Schreckenberger, C Lange-Asschenfeld, M Lochmann, K Mann, ... Neuroimage 22 (2), 637-644, 2004 | 226 | 2004 |
| Impaired sleep quality and sleep duration in smokers—results from the G erman M ulticenter S tudy on N icotine D ependence S Cohrs, A Rodenbeck, D Riemann, B Szagun, A Jaehne, J Brinkmeyer, ... Addiction biology 19 (3), 486-496, 2014 | 222 | 2014 |
| An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels J De Leon, G Schoretsanitis, RL Smith, E Molden, A Solismaa, N Seppälä, ... Pharmacopsychiatry 55 (02), 73-86, 2022 | 215 | 2022 |
| The'atypicality'of antipsychotics: a concept re-examined and re-defined G Gründer, H Hippius, A Carlsson Nature Reviews Drug Discovery 8 (3), 197-202, 2009 | 213 | 2009 |
| Elevated [18F] fluorodopamine turnover in brain of patients with schizophrenia: an [18F] fluorodopa/positron emission tomography study Y Kumakura, P Cumming, I Vernaleken, HG Buchholz, T Siessmeier, ... Journal of Neuroscience 27 (30), 8080-8087, 2007 | 183 | 2007 |
| The role of imaging in proof of concept for CNS drug discovery and development DF Wong, J Tauscher, G Gründer Neuropsychopharmacology 34 (1), 187-203, 2009 | 179 | 2009 |
